dna-istock-518143098-ralwel--2
ralwel / iStockphoto.com
19 September 2018AmericasPat Carson and Mira Atanassova Mulvaney

CRISPR patents: guidance from US courts

The CRISPR gene manipulation system—an adaptive immune system used by microbes to defend against viruses, which has been repurposed into an efficient and reliable gene-editing technique in mammalian cells—has taken the genome engineering world by storm and has attracted much attention for its immense promise in the development of innovative diagnostic tools and therapies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
2 July 2026   A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over allegations of trade secret misuse during a bidding process.
Americas
30 June 2026   Sandoz has filed FDA applications for generic versions of Eli Lilly’s blockbuster drugs, marking an early step towards potential competition in the fast-growing GLP-1 market.
Americas
25 June 2026   The Federal Circuit has brought Paxlovid’s infringement case to an end, serving as a reminder that even minor changes to patent language can have major consequences.